25 episodes

After Animals uncovers trends and stories at the cutting edge of the global post-animal movement. What does a future look like, in which food, fashion and entertainment no longer have to exploit animals to be successful? In each episode, we share a remarkable and inspiring story about someone who is forging a more compassionate future for us all. After Animals seeks to activate a kinder, more compassionate world through innovation.

After Animals Podcast Ulara Nakagawa & Sharanya Krishna Prasad

    • Business
    • 5.0 • 18 Ratings

After Animals uncovers trends and stories at the cutting edge of the global post-animal movement. What does a future look like, in which food, fashion and entertainment no longer have to exploit animals to be successful? In each episode, we share a remarkable and inspiring story about someone who is forging a more compassionate future for us all. After Animals seeks to activate a kinder, more compassionate world through innovation.

    Can Investing in the Stock Market be Cruelty-Free? - Beyond Investing's Claire Smith

    Can Investing in the Stock Market be Cruelty-Free? - Beyond Investing's Claire Smith

    This episode features impact investor and entrepreneur Claire Smith. Claire is a well-known figure in the conscious capitalism space, who created the humane investment platform Beyond Investing. In 2019, Claire and her team launched what the media has dubbed the world’s first vegan-themed ETF (VEGN). An ETF is an investment product that consists of a bundle of securities that you can buy or sell on a stock exchange just like stocks and Claire's screens out all animal exploitation and fossil fuel from a US market benchmark. It's currently listed as a tracker fund on the NYSE. Claire is also Chief Investment Officer at Beyond Impact, which undertakes VC investment in vegan, plant-based, and cruelty-free businesses. 
    Episode highlights include: 
    What is an ETF? How does it work? Can "regular people" invest in one? How Claire and her team came up with the idea to start the world's first vegan ETF. The unique data-driven process by which they evaluate companies in the ETF to ensure they are ethical, sustainable, and cruelty-free. How exactly to get started if you want to put money into an ESG (Environmental, Social, and Governance) or vegan-themed fund such as Claire's. Why Claire invests in diverse founding teams through her venture capital firm and how she identifies successful startups.Beyond Investing's website: https://beyondinvesting.com/
    Support the show (https://www.afteranimals.com/support-us)

    • 1 hr 9 min
    Roundup: This Year's Top 10 Food Tech Moments

    Roundup: This Year's Top 10 Food Tech Moments

    For our final episode of the year, we're sharing a roundup of top 10 animal-free food news from 2021! Sharanya and Ulara dive into some of the biggest breakthroughs and exciting updates from the cutting-edge food technology companies they’ve featured on the podcast so far.  Note: May drool while listening. Don't say we didn't warn you! 

    Some episode highlights include: 
    Super protein made from fungi harvested from Yellowstone National Park now available!Lab-grown mouse meat cat treats are (finally) ready for sale!3-D meat is getting rave reviews from top global chefs, to be served in high-end restaurants soon....and so much more, including major updates on cultured seafood, plant-based chicken and fish, bee-free honey...Support the show (https://www.afteranimals.com/support-us)

    • 41 min
    The Breakthrough Technology We Can Use Instead of Animal Experiments - NETRI's Thibault Honegger

    The Breakthrough Technology We Can Use Instead of Animal Experiments - NETRI's Thibault Honegger

    Can tiny, lab-made replicas of the human brain FINALLY lead us to cure devastating illnesses such as Parkinson's, Alzheimer's, and brain cancer? NETRI is a fast-rising French biotech startup that believes they absolutely can... while also eliminating costly, often inaccurate animal experiments along the way. Founded in 2018, NETRI has already grown to 30 staff globally, boasting a handful of organ-on-a-chip technology patents, including their flagship technology: brain-on-a-chip. Excitingly, NETRI works hand in hand with major clients and partners across the cosmetic, pharmaceutical, and medical industries to advance these giant industries towards a better future of health for us all. So we are thrilled to share this episode featuring Thibault Honeggar, CEO and Co-Founder of NETRI, to give us the scoop on their trailblazing work. In this fascinating and engaging interview, you'll learn all you need to know about brain-on-a-chip: the tiny technology that will have a huge impact on the future of brain health.
    NETRI website: https://netri.fr/about/ 
    Support the show (https://www.afteranimals.com/support-us)

    • 1 hr 1 min
    This Company Makes Mini Replicas of the Human Body to Test on... Instead of Animals - TissUse's Dr. Reyk Horland

    This Company Makes Mini Replicas of the Human Body to Test on... Instead of Animals - TissUse's Dr. Reyk Horland

    German biotechnology pioneer TissUse is making mini human bodies in the lab. Sounds creepy? It's not. Here's why: TissUse has developed a unique, patent-protected "human-on-a-chip" platform. Since 2012, this revolutionary technology has been replacing animal testing for pharmaceutical drug development, cosmetics, consumer products, chemicals, and food safety. TissUse's "human-on-a-chip" consists of miniaturized tissues and organs that can be connected together to mimic the whole human body. Unlike other single "organ-on-a-chip" platforms, TissUse's multi-organ chips help provide a more accurate picture of a human body's reaction to foods, medicines, chemicals, and even diseases. In this episode, TissUse's CEO Dr. Reyk Horland takes us on a journey from the inception of the idea of the technology to a look into a future without animal testing.
    TissUse website: https://www.tissuse.com/en/


    Support the show (https://www.afteranimals.com/support-us)

    • 52 min
    Lab-Made Human Hearts to End Animal Testing? This Tiny Technology Has Huge Potential - TARA Biosystems' Misti Ushio

    Lab-Made Human Hearts to End Animal Testing? This Tiny Technology Has Huge Potential - TARA Biosystems' Misti Ushio

    TARA Biosystems has raised $21.3 million to date and is the world’s only company that generates human cardiac tissue—outside of the human body. Instead of testing on animals, researchers will be able to test drugs right on actual human tissue and the industry will be able to save time, money and unnecessary animal suffering throughout the drug development process.

    In this episode, we feature an eye-opening interview with TARA Biosystems’ CEO Misti Ushio, to learn more about how their breakthrough technology came to be, how it works, the enormous potential it holds, as well as some of the challenges that still need to be overcome for it and other similar technologies to be used widely in the “real world.” In the episode intro, Sharanya and Ulara share some key stats and figures from the animal testing alternatives landscape, and discuss some of the surprisingly major players already involved in the emerging space, including government leaders and regulatory agencies. 

    TARA Biosystems’ website: https://tarabiosystems.com/ 
    The article we refer to in the episode is “The next phase of drug creation: Why animal models are on the brink of extinction” via Pharma Manufacturing: https://www.pharmamanufacturing.com/articles/2021/the-next-phase-of-drug-creation/ 


    Support the show (https://www.afteranimals.com/support-us)

    • 55 min
    Replay: This Lab-Grown Shrimp Startup is Blowing Up. Here’s Why - Shiok Meats’ Sandhya Sriram

    Replay: This Lab-Grown Shrimp Startup is Blowing Up. Here’s Why - Shiok Meats’ Sandhya Sriram

    In this episode, we revisit our Season 1 conversation with Dr. Sandhya Sriram, CEO and Co-Founder of cultured seafood maker Shiok Meats. In December 2020, Singapore became the first country to approve cultured cell-based meat for human consumption. So for this replay, we’ve included a special segment to discuss how diners are reacting to trying cultured meat (chicken) in the real world, for the first time! We then go back to our original episode in which we talk with Dr. Sriram about how her fast-rising startup initially raised $4.6 million in funding AND created an MVP (minimum viable product)… in under a year. Now, that funding has hit over $20 million, and Shiok Meats is poised to become the first cultured cell-based crustacean meat company to have their products widely available in the market by 2022. Dr. Sandhya Sriram takes us into the fascinating world of lab-grown shrimp, crab and lobster, and also shares some valuable tips and insights for rising entrepreneurs in the space. 
    Shiok Meats website: https://shiokmeats.com/
    Music interlude created by Lee Rosevere.
    Support the show (https://www.afteranimals.com/support-us)

    • 50 min

Customer Reviews

5.0 out of 5
18 Ratings

18 Ratings

KMK 1 ,

Revolutionary. Necessary.

This podcast not only highlights topics that uncover and identify our shared humanity, it seeks to spark the imagination and intention for a better future.

Every episode makes me feel closer to the heart of life and keeps me inspired by how far we’ve come — but no longer ignorant about the work it takes to keep moving in the right direction.

alex.etc ,

Good podcast.

I really like her passion for the subject.

Top Podcasts In Business

Ramsey Network
NPR
iHeartPodcasts
Guy Raz | Wondery
Andy Frisella #100to0
Jocko DEFCOR Network